GE HEALTHCARE TECHNOLOGIES INC.
Fiscal years labelled by the calendar year in which they end. Bars in $ billions; per-share figures as reported.
CAPITALIZATION 12/31/25
| ($ millions) | Amount | % |
|---|---|---|
| Total debt | 10,511 | 50.3 |
| Stockholders' equity | 10,379 | 49.7 |
| Total capitalization | 20,890 | 100.0 |
454,891,786 shares outstanding at 22 April 2026 (cover page of the 10-Q filed 29 April 2026).
LONG-TERM DEBT 12/31/25
| ($ millions) | Amount |
|---|---|
| Long-term debt, incl. current maturities | 10,003 |
| Long-term debt, noncurrent | 9,495 |
| Current maturities | 502 |
| Short-term borrowings / commercial paper | 508 |
CAPITAL STOCK 12/31/25
| Common shares authorized | 1,000,000,000 |
| Common shares issued | 458,844,209 |
| Treasury shares | 3,107,626 |
| Par or stated value per share ($) | 0.01 |
| Outstanding at 4/22/26 | 454,891,786 |
DIVIDENDS DECLARED/PAID
| Fiscal year | Per share $ | Payout % |
|---|---|---|
| 2025 | 0.14 | 3.1 |
| 2024 | 0.12 | 2.9 |
| 2023 | 0.12 | 4.0 |
| 2022 | – | – |
| 2021 | – | – |
HISTORY AND BUSINESS
HISTORY: Incorporated in Delaware. Formerly known as GE Healthcare Holding LLC (to 14 December 2022).
BUSINESS: Classified by the SEC under Standard Industrial Classification 3844, X-Ray Apparatus & Tubes & Related Irradiation Apparatus. Large accelerated filer. Principal executive office: 500 West Monroe Street, Chicago, IL 60661. Fiscal year ends December 31. For a description of the business, see Item 1 of the latest 10-K.
CONSOLIDATED INCOME ACCOUNT, YEARS ENDED
| ($ millions) | 12/31/25 | 12/31/24 | 12/31/23 |
|---|---|---|---|
| Revenues | 20,625 | 19,672 | 19,552 |
| Gross profit | 8,248 | 8,205 | 7,922 |
| Research and development | 1,260 | 1,311 | 1,205 |
| Selling, general and administrative | 4,225 | 4,269 | 4,282 |
| Depreciation and amortization | 287 | 268 | 248 |
| Operating income | 2,763 | 2,625 | 2,435 |
| Income before income taxes | 2,768 | 2,581 | 2,361 |
| Income taxes | 614 | 531 | 743 |
| Net income | 2,084 | 1,993 | 1,568 |
| Earned per share, diluted ($) | 4.55 | 4.34 | 3.03 |
| Dividends per share ($) | 0.14 | 0.12 | 0.12 |
CONSOLIDATED BALANCE SHEET
| ($ millions) | 12/31/25 | 12/31/24 |
|---|---|---|
| Cash and equivalents | 4,492 | 2,874 |
| Inventories | 2,234 | 1,939 |
| Total current assets | 12,501 | 9,901 |
| Goodwill | 13,489 | 13,136 |
| Total assets | 36,906 | 33,089 |
| Total current liabilities | 9,105 | 9,553 |
| Long-term debt | 9,495 | 7,449 |
| Total liabilities | 26,307 | 24,437 |
| Stockholders' equity | 10,379 | 8,446 |
| Total liabilities and equity | 36,906 | 33,089 |
TEN-YEAR STATISTICS: FISCAL YEARS ($ millions except per share)
| Fiscal year ended | Revenues | Oper. income | Net income | Net margin % | EPS diluted $ | Div. per share $ | Oper. cash flow | Capital expend. | Free cash flow | Total assets | Total liabilities | Total debt | Stockholders' equity | ROE % | Debt / equity |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12/31/25 | 20,625 | 2,763 | 2,084 | 10.1 | 4.55 | 0.14 | 1,987 | 482 | 1,505 | 36,906 | 26,307 | 10,511 | 10,379 | 20.1 | 1.01 |
| 12/31/24 | 19,672 | 2,625 | 1,993 | 10.1 | 4.34 | 0.12 | 1,955 | 401 | 1,554 | 33,089 | 24,437 | 10,453 | 8,446 | 23.6 | 1.24 |
| 12/31/23 | 19,552 | 2,435 | 1,568 | 8.0 | 3.03 | 0.12 | 2,101 | 387 | 1,714 | 32,454 | 25,144 | 10,448 | 7,133 | 22.0 | 1.46 |
| 12/31/22 | 18,341 | 2,522 | 1,916 | 10.4 | 4.22 | – | 2,134 | 310 | 1,824 | 27,539 | 17,947 | 8,264 | 9,357 | 20.5 | 0.88 |
| 12/31/21 | 17,585 | 2,795 | 2,247 | 12.8 | 4.95 | – | 1,607 | 248 | 1,359 | – | – | – | 16,676 | 13.5 | – |
Net margin = net income ÷ revenues; ROE = net income ÷ year-end stockholders’ equity; total debt = long-term debt including current maturities plus short-term borrowings/commercial paper, as tagged in XBRL; free cash flow = operating cash flow − purchases of property, plant and equipment; d = derived as total assets − total equity where the filing does not tag total liabilities; – = not reported in XBRL for that year.
REGISTRANT:
GE HealthCare Technologies Inc.
CIK 1932393 · EIN 88-2515116
PRINCIPAL OFFICE:
500 West Monroe Street, Chicago, IL 60661
Tel.: 833-735-1139
INCORPORATED:
Delaware
INDUSTRY (SEC SIC CODE):
3844 · X-Ray Apparatus & Tubes & Related Irradiation Apparatus
FILER STATUS:
Large accelerated filer
LATEST ANNUAL REPORT:
10-K for period ended 12/31/25, filed 4 February 2026
FORMER NAMES:
GE Healthcare Holding LLC
Sources: SEC XBRL company facts (all financial figures) · SEC submissions (registrant, address, SIC, filings) · annual reports: 10-K FY2025 (filed 2/4/26) · 10-K FY2024 (filed 2/13/25) · 10-K FY2023 (filed 2/6/24). Values are the latest figures filed for each fiscal year (restated where a later 10-K restated them). Ratios and free cash flow are Pathos calculations from those figures. Retrieved 31 October 2026.
Data from SEC filings. © 2026 Pathos Investments · pathosinvestments.com · For educational purposes only. Not investment advice.